Home »
Patients with mitral and tricuspid valve regurgitation, a condition sometimes called “leaky heart valves,” appeared to do better after two years if they had a tricuspid valve repair at the time of mitral valve surgery,
The Lundquist Institute’s investigators have developed a novel mouse model that displays the most comprehensive set of A-T symptoms which provides for the very first time a resource to not only clarify the mechanisms of
In order for cancer cells to develop into a severe tumor, they need to be able to escape attack by the patient’s own immune system. This is why immunotherapeutic treatment that helps the immune system
At the earliest stages of human embryonic development, a small collection of cells known as human embryonic stem cells (hESCs) orchestrates growth and differentiation, eventually giving rise to highly specialized human tissues. As pluripotent cells—progenitors
The proposed reauthorization of the federal Child Abuse Prevention and Treatment Act, also known as CAPTA—the foundational child abuse prevention legislation in the United States—has the potential to drastically and positively impact infants exposed to
Calling all candy lovers! Ohio State University researchers are seeking volunteers to help with a “sweet” new study. Researchers are looking for about 3,000 participants to smell and consume a piece of hard candy every
Researchers in Japan have developed a vaccination strategy in mice that promotes the production of antibodies that can neutralize not only SARS-CoV-2 but a broad range of other coronaviruses as well. If successfully translated to
Scientists have found evidence of a resistant form of malaria in Uganda, a worrying sign that the top drug used against the parasitic disease could ultimately be rendered useless without more action to stop its
Researchers at CÚRAM, the SFI Research Centre for Medical Devices based at NUI Galway, have shown how the simple act of walking can power an implantable stimulator device to speed up treatment of musculoskeletal diseases.
Innovators at Purdue University and Houston Methodist Research Institute have created a novel strategy for developing an effective vaccine for a widespread form of tuberculosis. Mycobacterium tuberculosis (Mtb) is a leading cause of death worldwide,